Human Tissue Authority

The regulator for human tissue and organs

Guidance for professionals

The filter and search function on this page allows you to refine down the full list of guidance that we provide for professionals to find specific items. Common searches for the HTA codes of practice and standards, licensing, fees and inspection information or for specific information for each of our regulated sectors can be found using the menu items above.

This guidance provides a comprehensive explanation of the responsibilities of toxicologists under the Human Tissue Act 2004.
  • Toxicology
The HTA has produced guidance for professionals working in NHS hospitals, independent hospitals and abortion clinics
  • Post mortem
  • Pregnancy loss
About post mortem sector HTA Reportable Incidents, including information about how to log HTARIs
  • HTA Reportable Incident (HTARI)
The standards that establishments licensed under an HTA research licence should meet
Regulation of the Post Mortem Sector 2014 - 16: What we have learnedNovember 2016This report is aimed particularly at Designated Individuals (DI), Persons Designated (PD), and any staff working under their direction in the conduct of licensed activities: predominantly pathologists and anatomical pathology technologists. The contextual sector information and the learning gained from the...
  • Post mortem
  • HTA Reportable Incident (HTARI)
  • Mortuaries
  • News and events
The transportation and delivery of tissues or cells intended for human application, including to or from other countries
  • Import and export
HTA policy on human tissue xenografts as relevant material, the consent implications and the licensing requirements under the HT Act 2004.
  • xenografts
HTA position statement on the regulation of dendritic cells and white blood cells other than granulocytes under the Human Tissue (Quality and Safety for Human Application) Regulations 2007
  • Dendritic cells
How to provide a third party with the authority to undertake licensable activities on behalf of a licensed establishment
  • Third party
Notice for Designated Individuals in the Human Application sector regarding Viaspan solution, which is distributed by Bristol Myers-Squibb.

Pages

More...
More...